论文部分内容阅读
目的:观察乌芪参苓白术汤加减联合化疗中晚期大肠癌的临床疗效。方法:46例癌的患者随机分成两组:治疗组(乌芪参苓白术汤加减联合化疗治疗)26例、对照组(单用化疗治疗)20例。两组基本情况差异无显著性(P>0.05),观察比较两组治疗后的有效控制率(CR+PR)。结果:治疗组有效率为65.4%,明显优于对照组40.0%,差异有显著性(P<0.05)。结论:乌芪参苓白术汤加减联合化疗中晚期大肠癌有效率明显高于单纯化疗组且能减轻化疗所致不良反应,提高了患者生存质量,延长了生存期。
Objective: To observe the clinical efficacy of Wuqi Shenling Baizhu Decoction in combination with chemotherapy for advanced colorectal cancer. Methods: Forty-six patients with cancer were randomly divided into two groups: treatment group (Wuqi Shenling Baizhu Decoction combined with chemotherapy) in 26 cases, control group (chemotherapy alone) in 20 cases. There was no significant difference between the two groups (P> 0.05). The effective rate of control (CR + PR) after treatment was observed and compared between the two groups. Results: The effective rate of the treatment group was 65.4%, which was significantly better than that of the control group (40.0%), the difference was significant (P <0.05). Conclusion: Wuqi Shenling Baizhu decoction combined with chemotherapy of advanced colorectal cancer was significantly higher than the simple chemotherapy group and can reduce chemotherapy-induced adverse reactions, improve patient quality of life and prolong survival.